Inventor

LINZ WOLFGANG

DE25 patents

⚠️ This page may combine multiple inventors who share the name “LINZ WOLFGANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LINZ WOLFGANG

HOECHST AG

USPA benzolyguanidines

Benzoylguanidines, a process for their preparation, their use as medicaments and medicaments containing them

Method for the treatment of cardiac and of vascular hypertrophy and hyperplasia

Amino-substituted benzoylguanidines, process for their preparation, their use as a medicament and medicament containing them

Method for the treatment of cardiac and of vascular hypertrophy and hyperplasia

3-amidochromanylsulfonyl(thio)ureas, processes for their preparation, their use, and pharmaceutical preparations comprising them

Substituted benzenesulfonylureas and thioureas process for their preparation and their use as pharmaceuticals

Substituted benzenesulfonylureas and -thioureas- process for their preparation and their use as pharmaceuticals

Substituted benzenesulfonylureas and thioureas-process for their preparation and their use as pharmaceuticals

Angiotensin II receptor antagonists for the treatment of disturbances in cardiac rhythm

Substituted benzenesulfonylureas and -thioureas--process for their preparation and their use as pharmaceuticals

Substituted benzenesulfonylureas and -thioureas-process for their preparation and their use as pharmaceuticals

Azole derivatives, process for their preparation and their use

Amino acid derivatives with renin-inhibiting properties, a process for the preparation thereof, agents containing these, and the use thereof

Substituted chromanysulfonyl (thio) ureas, processing for their preparation and pharmaceutical uses thereof

Benzothiazinone derivatives, and pharmaceuticals containing them

AVENTIS PHARMA GMBH

Mercaptoacetylamide derivatives, a process for their preparation and their use

Use of inhibitors of the sodium-hydrogen exchanger for preparing a medicament for preventing age-related disorders, and for prolonging life

Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitor

Use of inhibitors of the sodium-hydrogen exchanger for the production of a medicament for decreasing undesired effects of substrates of the heart

Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy and advanced glycation end-product associated diseases

SANOFI AVENTIS DEUTSCHLAND

Use of PPAR agonists for the treatment of congestive heart failure

Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy and advanced glycation end-product associated diseases

(unassigned)

Substituted benzenesulfonylureas and -thioureas-processes for their preparation and their use as pharmaceuticals

LINZ WOLFGANG

Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitor